Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds
ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer
Half Of Women Complete Full Hormone Therapy Regimen
Surveillance Colonoscopy Cost-Effective For High-Risk
Surveillance Treatment Option For Low-Risk Prostate Cancer
Toxicity, Non-Cancer Deaths Increase With Combo Therapy
Time Spent Sitting Associated With Total Mortality, Study Finds
Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds
NCI-Approved Clinical Trials
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









